Celastrol reduces cholestatic liver injury by inhibiting specific protein

This report highlights the potential of celastrol to reduce cholestatic liver injury by targeting a specific protein involved in the disease process. Cholestasis leads to impaired bile flow and accumulation of toxic bile acids, causing inflammation and liver cell damage. The findings suggest a possible therapeutic approach for managing cholestatic liver conditions.

Originally published by gnews